The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA
Abstract
Interferons (IFNs) are critical for protection from viral infection, but the pathways linking virus recognition to IFN induction remain poorly understood. Plasmacytoid dendritic cells produce vast amounts of IFN-alpha in response to the wild-type influenza virus. Here, we show that this requires endosomal recognition of influenza genomic RNA and signaling by means of Toll-like receptor 7 (TLR7) and MyD88. Single-stranded RNA (ssRNA) molecules of nonviral origin also induce TLR7-dependent production of inflammatory cytokines. These results identify ssRNA as a ligand for TLR7 and suggest that cells of the innate immune system sense endosomal ssRNA to detect infection by RNA viruses.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, several RNA structural features have been described as immunostimulatory due to interactions with various RNA sensors such as Toll-like receptors, RIG-I, and PKR.”
From Sequence-engineered mRNA without chemical nucleoside modifications enables an effective protein therapy in large animals (2015) · cites this paper as [8]
Citations
Cites
Takeda, K., Kaisho, T., & Akira, S. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141126 · Cited by 6,143
Jego, G., Palucka, A. K., Blanck, J.-P., Chalouni, C., Pascual, V., & Banchereau, J. (2003) · Immunity · doi:10.1016/s1074-7613(03)00208-5 · Cited by 1,067
Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology
Asselin‐Paturel, C., Boonstra, A., Dalod, M., Durand, I., Yessaad, N., Dezutter‐Dambuyant, C., Vicari, A. P., O’Garra, A., Biron, C. A., Brière, F., et al. (2001) · Nature Immunology · doi:10.1038/ni736 · Cited by 1,021
Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848
Jurk, M., Heil, F., Vollmer, J., Schetter, C., Krieg, A. M., Wagner, H., Lipford, G., & Bauer, S. (2002) · Nature Immunology · doi:10.1038/ni0602-499 · Cited by 838
Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization
Cella, M., Facchetti, F., Lanzavecchia, A., & Colonna, M. (2000) · Nature Immunology · doi:10.1038/79747 · Cited by 790
Skehel, J. J., Bayley, P. M., Brown, E. B., Martin, S. R., Waterfield, M. D., White, J. M., Wilson, I. A., & Wiley, D. C. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.4.968 · Cited by 726
Subcellular Localization of Toll-Like Receptor 3 in Human Dendritic Cells
Matsumoto, M., Funami, K., Tanabe, M., Oshiumi, H., Shingai, M., Seto, Y., Yamamoto, A., & Seya, T. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3154 · Cited by 723
Nakano, H., Yanagita, M., & Gunn, M. D. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.8.1171 · Cited by 715
Krug, A., Luker, G. D., Barchet, W., Leib, D. A., Akira, S., & Colonna, M. (2003) · Blood · doi:10.1182/blood-2003-08-2674 · Cited by 696
Häcker, H., Mischak, H., Miethke, T., Liptay, S., Schmid, R. M., Sparwasser, T. D., Heeg, K. M., Lipford, G. B., & Wagner, H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.21.6230 · Cited by 670
Flagged first, then by citations
Research works printed but not linked: 3
- Wkly. Epidemiol. Rec. No. 78 (2003), p. 39.
- C. Reis e Sousa, Semin. Immunol.16, 24 (2004).
- This work was funded by Cancer Research UK. We thank J. Skehel for providingstrain X31 for RNA isolation; M. Albert for wild-type PR8 flu; A. Grassauer and H. Unger for the ΔNS1 flu; A. Steinkasserer for pGEM4Z/GFP; G. Schiavo and G. Hammond for help with liposome preparation; and F. Batista I. Kerr J. Skehel R. Treisman and members of the Immunobiology Laboratory for advice and critical review of the manuscript.
Cited by
Sorted by citations
Items 101–200 of 1,013
siRNA vs. shRNA: Similarities and differences
Rao, D. D., Vorhies, J. S., Senzer, N. N., & Nemunaitis, J. J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.04.004 · Cited by 702
Toll-Like Receptors: Linking Innate and Adaptive Immunity
Pasare, C., & Medzhitov, R. M. (2005) · Advances in experimental medicine and biology · doi:10.1007/0-387-24180-9_2 · Cited by 666
A Tlr7 translocation accelerates systemic autoimmunity in murine lupus
Subramanian, S., Tus, K., Li, Q., Wang, A., Tian, X.-H., Zhou, J., Liang, C., Bartov, G., McDaniel, L. D., Zhou, X. J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603912103 · Cited by 651
Rothenfußer, S., Goutagny, N., DiPerna, G., Gong, M., Monks, B. G., Schoenemeyer, A., Yamamoto, M., Akira, S., & Fitzgerald, K. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.5260 · Cited by 645
Influenza virus activates inflammasomes via its intracellular M2 ion channel
Ichinohe, T., Pang, I. K., & Iwasaki, A. (2010) · Nature Immunology · doi:10.1038/ni.1861 · Cited by 632
Developing mRNA-vaccine technologies
Schlake, T., Thess, A., Fotin-Mleczek, M., & Kallen, K.-J. (2012) · RNA Biology · doi:10.4161/rna.22269 · Cited by 622
The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor
Ewald, S. E., Lee, B. L., Lau, L., Wickliffe, K. E., Shi, G., Chapman, H. A., & Barton, G. M. (2008) · Nature · doi:10.1038/nature07405 · Cited by 651
The Specific and Essential Role of MAVS in Antiviral Innate Immune Responses
Sun, Q., Sun, L., Liu, H.-H., Chen, X., Seth, R. B., Forman, J., & Chen, Z. J. (2006) · Immunity · doi:10.1016/j.immuni.2006.04.004 · Cited by 604
Jensen, S., & Thomsen, A. R. (2012) · Journal of Virology · doi:10.1128/jvi.05738-11 · Cited by 604
DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88
Tarallo, V., Hirano, Y., Gelfand, B. D., Dridi, S., Kerur, N., Kim, Y., Cho, W. G., Kaneko, H., Fowler, B. J., Bogdanovich, S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.036 · Cited by 592
Advances in COVID-19 mRNA vaccine development
Fang, E., Liu, X., Li, M., Zhang, Z., Song, L., Zhu, B., Wu, X., Liu, J., Zhao, D., & Li, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00950-y · Cited by 601
Discriminating self from non-self in nucleic acid sensing
Schlee, M., & Hartmann, G. (2016) · Nature reviews. Immunology · doi:10.1038/nri.2016.78 · Cited by 594
Zheng, M., & Kanneganti, T. (2020) · Immunological Reviews · doi:10.1111/imr.12909 · Cited by 602
Pathogen recognition in the innate immune response
Kumar, H., Kawai, T., & Akira, S. (2009) · Biochemical Journal · doi:10.1042/bj20090272 · Cited by 609
TLR7 gain-of-function genetic variation causes human lupus
Brown, G. J., Cañete, P. F., Wang, H., Medhavy, A., Bones, J., Roco, J. A., He, Y., Qin, Y., Cappello, J., Ellyard, J. I., et al. (2022) · Nature · doi:10.1038/s41586-022-04642-z · Cited by 596
Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists
Vollmer, J., & Krieg, A. Μ. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.12.008 · Cited by 594
Opportunities and Challenges in the Delivery of mRNA-Based Vaccines
Wadhwa, A., Aljabbari, A., Lokras, A., Foged, C., & Thakur, A. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020102 · Cited by 584
Nucleic acid recognition by the innate immune system
Barbalat, R., Ewald, S. E., Mouchess, M. L., & Barton, G. M. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101340 · Cited by 577
Pathogen recognition with Toll-like receptors
Kawai, T., & Akira, S. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.02.007 · Cited by 589
Hemmi, H., Takeuchi, O., Sato, S., Yamamoto, M., Kaisho, T., Sanjo, H., Kawai, T., Hoshino, K., Takeda, K., & Akira, S. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040520 · Cited by 576
Mibayashi, M., Martínez‐Sobrido, L., Loo, Y., Cardenas, W. B., Gale, M., & García‐Sastre, A. (2006) · Journal of Virology · doi:10.1128/jvi.01265-06 · Cited by 574
Apétoh, L., Ghiringhelli, F., Tesnière, A., Criollo, A., Ortiz, C., Lidereau, R., Mariette, C., Chaput, N., Mira, J. P., Delaloge, S., et al. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00573.x · Cited by 604
Absence of autophagy results in reactive oxygen species-dependent amplification of RLR signaling
Tal, M. C., Sasai, M., Lee, H. K., Yordy, B., Shadel, G. S., & Iwasaki, A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807694106 · Cited by 595
Design of Noninflammatory Synthetic siRNA Mediating Potent Gene Silencing in Vivo
Judge, A. D., Bola, G., Lee, A. C. H., & MacLachlan, I. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.11.002 · Cited by 571
A facile method for the removal of dsRNA contaminant from in vitro-transcribed mRNA
Baiersdörfer, M., Boros, G., Muramatsu, H., Mahiny, A., Vlatkovic, I., Sahin, U., & Karikó, K. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.02.018 · Cited by 569
The interferon system of teleost fish
Robertsen, B. (2005) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2005.01.010 · Cited by 564
Querec, T. D., Bennouna, S., Alkan, S., Laouar, Y., Gorden, K. B., Flavell, R. A., Akira, S., Ahmed, R., & Pulendran, B. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051720 · Cited by 557
Decoding Toll-like receptors: Recent insights and perspectives in innate immunity
Kawai, T., Ikegawa, M., Ori, D., & Akira, S. (2024) · Immunity · doi:10.1016/j.immuni.2024.03.004 · Cited by 593
Oh, J. Z., Ravindran, R., Chassaing, B., Carvalho, F. A., Maddur, M. S., Bower, M., Hakimpour, P., Gill, K. P., Nakaya, H. I., Yarovinsky, F., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.08.009 · Cited by 541
Recognition of Endogenous Nucleic Acids by the Innate Immune System
Roers, A., Hiller, B., & Hornung, V. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.002 · Cited by 541
Gautier, G., Humbert, M., Deauvieau, F., Scuiller, M., Hiscott, J. B., Bates, E. E. M., Trinchieri, G., Caux, C., & Garrone, P. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041964 · Cited by 548
Robbins, S. H., Walzer, T., Dembélé, D., Thibault-Carpentier, C., Defays, A., Bessou, G., Xu, H., Vivier, É., Sellars, M., Pierre, P., et al. (2008) · Genome biology · doi:10.1186/gb-2008-9-1-r17 · Cited by 582
Honda, K., Yanai, H., Mizutani, T., Negishi, H., Shimada, N., Suzuki, N., Ohba, Y., Takaoka, A., Yeh, W., & Taniguchi, T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406933101 · Cited by 526
mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases
Maruggi, G., Zhang, C., Li, J., Ulmer, J. B., & Yu, D. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.01.020 · Cited by 507
Toll-like receptors in bony fish: From genomics to function
Palti, Y. (2011) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2011.03.006 · Cited by 526
Uccellini, M. B., Broughton, C., Mackay, F., Akira, S., Marshak‐Rothstein, A., & Rifkin, I. R. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031942 · Cited by 528
THE EVOLUTION OF ADAPTIVE IMMUNITY
Pancer, Z., & Cooper, M. D. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090542 · Cited by 541
Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus
Christensen, S. R., Kashgarian, M. J., Alexopoulou, L., Flavell, R. A., Akira, S., & Shlomchik, M. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050338 · Cited by 521
Vollmer, J., Tluk, S., Schmitz, C., Hamm, S., Jurk, M., Forsbach, A., Akira, S., Kelly, K. M., Reeves, W. H., Bauer, S., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051696 · Cited by 515
Thess, A., Grund, S., Mui, B. L., Hope, M. J., Baumhof, P., Fotin-Mleczek, M., & Schlake, T. (2015) · Molecular Therapy · doi:10.1038/mt.2015.103 · Cited by 513
The many faces of the anti-COVID immune response
Vardhana, S. A., & Wolchok, J. D. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20200678 · Cited by 513
Steinhagen, F., Kinjo, T., Bode, C., & Klinman, D. M. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.08.002 · Cited by 516
Essential role of IPS-1 in innate immune responses against RNA viruses
Kumar, H., Kawai, T., Kato, H., Sato, S., Takahashi, K., Coban, C., Yamamoto, M., Uematsu, S., Ishii, K. J., Takeuchi, O., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060792 · Cited by 503
The landscape of mRNA nanomedicine
Huang, X., Kong, N., Zhang, X., Cao, Y., Langer, R., & Tao, W. (2022) · Nature Medicine · doi:10.1038/s41591-022-02061-1 · Cited by 511
Toll-like Receptors and Type I Interferons
Uematsu, S., & Akira, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r700009200 · Cited by 497
Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine
Li, C., Lee, A., Grigoryan, L., Arunachalam, P. S., Scott, M. K. D., Trisal, M., Wimmers, F., Sanyal, M., Weidenbacher, P. A., Feng, Y., et al. (2022) · Nature Immunology · doi:10.1038/s41590-022-01163-9 · Cited by 505
COVID-19-associated fungal infections
Hoenigl, M., Seidel, D., Sprute, R., Cunha, C., Oliverio, M., Goldman, G. H., Ibrahim, A. S., & Carvalho, A. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01172-2 · Cited by 482
Intratumoural administration and tumour tissue targeting of cancer immunotherapies
Melero, I., Álvarez, E. C., Álvarez, M., Champiat, S., & Marabelle, A. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00507-y · Cited by 505
Conventional and unconventional mechanisms for capping viral mRNA
Decroly, É., Ferrón, F., Lescar, J., & Canard, B. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2675 · Cited by 495
Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential
Hanke, M. L., & Kielian, T. (2011) · Clinical Science · doi:10.1042/cs20110164 · Cited by 498
Human papillomavirus vaccine against cervical cancer: Opportunity and challenge
Wang, R., Pan, W. D., Lei, J., Huang, W., Li, Y., Wu, D., Gao, C., Ma, D., & Liao, S. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.11.039 · Cited by 523
Lee, J. Y., Zhao, L., Youn, H. S., Weatherill, A. R., Tapping, R. I., Feng, L., Lee, W. H., Fitzgerald, K. A., & Hwang, D. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312990200 · Cited by 493
NLRP3 inflammasome in endothelial dysfunction
Bai, B., Yang, Y., Wang, Q., Li, M., Tian, C., Liu, Y., Aung, L. H. H., Li, P., Yu, T., & Chu, X. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02985-x · Cited by 507
Aslam, R., Speck, E. R., Kim, M., Crow, A. R., Bang, K. W. A., Nestel, F. P., Ni, H., Lazarus, A. H., Freedman, J. J., & Semple, J. W. (2005) · Blood · doi:10.1182/blood-2005-06-2202 · Cited by 499
Uematsu, S., Sato, S., Yamamoto, M., Hirotani, T., Kato, H., Takeshita, F., Matsuda, M., Coban, C., Ishii, K. J., Kawai, T., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042372 · Cited by 488
Human Keratinocytes Express Functional Toll-Like Receptor 3, 4, 5, and 9
Lebre, M. C., van der Aar, A. M. G., van Baarsen, L. G. M., van Capel, T. M. M., Schuitemaker, J. H. N., Kapsenberg, M. L., & de Jong, E. C. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700530 · Cited by 517
Liotta, F., Angeli, R., Cosmi, L., Filì, L., Manuelli, C., Frosali, F., Mazzinghi, B., Maggi, L., Pasini, A., Lisi, V., et al. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0454 · Cited by 492
TLR7 Ligands Induce Higher IFN-α Production in Females
Berghöfer, B., Frommer, T., Haley, G., Fink, L., Bein, G., & Hackstein, H. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2088 · Cited by 484
Toll-like receptors and their ligands control mesenchymal stem cell functions
Pevsner‐Fischer, M., Morad, V., Cohen-Sfady, M., Rousso-Noori, L., Zanin‐Zhorov, A., Cohen, S. J., Cohen, I. R., & Zipori, D. (2006) · Blood · doi:10.1182/blood-2006-06-028704 · Cited by 484
Park, B., Brinkmann, M. M., Spooner, E., Lee, C. C., Kim, Y., & Ploegh, H. L. (2008) · Nature Immunology · doi:10.1038/ni.1669 · Cited by 478
Cell-mediated Protection in Influenza Infection
Thomas, P. G., Keating, R., Hulse-Post, D. J., & Doherty, P. C. (2006) · Emerging infectious diseases · doi:10.3201/eid1201.051237 · Cited by 466
Ligand-induced conformational changes allosterically activate Toll-like receptor 9
Latz, E., Verma, A., Visintin, A., Gong, M., Sirois, C. M., Klein, D. C. G., Monks, B. G., McKnight, C. J., Lamphier, M. S., Duprex, W. P., et al. (2007) · Nature Immunology · doi:10.1038/ni1479 · Cited by 462
Innate immunity to Toxoplasma gondii infection
Yarovinsky, F. (2014) · Nature reviews. Immunology · doi:10.1038/nri3598 · Cited by 462
Innate immune response to viral infection
Koyama, S., Ishii, K. J., Coban, C., & Akira, S. (2008) · Cytokine · doi:10.1016/j.cyto.2008.07.009 · Cited by 462
Innate Immunity in the Respiratory Epithelium
Parker, D., & Prince, A. S. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0011rt · Cited by 474
Triggering the Innate Antiviral Response through IRF-3 Activation
Hiscott, J. B. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r700002200 · Cited by 454
Toll-like receptor 4 (TLR4): new insight immune and aging
Kim, H., Kim, H., Lee, J., & Hwangbo, C. (2023) · Immunity & Ageing · doi:10.1186/s12979-023-00383-3 · Cited by 500
Induction and Regulation of IFNs During Viral Infections
Malmgaard, L. (2004) · Journal of Interferon & Cytokine Research · doi:10.1089/1079990041689665 · Cited by 456
Chemical Modification of siRNAs for In Vivo Use
Behlke, M. A. (2008) · Oligonucleotides · doi:10.1089/oli.2008.0164 · Cited by 464
Inflammatory mechanisms in the lung
Yu, J. (2008) · Journal of Inflammation Research · doi:10.2147/jir.s4385 · Cited by 462
Toll-like receptors: linking innate and adaptive immunity
Pasare, C., & Medzhitov, R. M. (2004) · Microbes and Infection · doi:10.1016/j.micinf.2004.08.018 · Cited by 461
Antiviral Signaling Through Pattern Recognition Receptors
Kawai, T., & Akira, S. (2006) · The Journal of Biochemistry · doi:10.1093/jb/mvm032 · Cited by 452
Zhang, Z., Ohto, U., Shibata, T., Krayukhina, E., Taoka, M., Yamauchi, Y., Tanji, H., Isobe, T., Uchiyama, S., Miyake, K., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.09.011 · Cited by 461
Robbins, M., Judge, A. D., & MacLachlan, I. (2009) · Oligonucleotides · doi:10.1089/oli.2009.0180 · Cited by 463
Detection of Microbial Infections Through Innate Immune Sensing of Nucleic Acids
Tan, J. X., Sun, L., Chen, J., & Chen, Z. J. (2018) · Annual Review of Microbiology · doi:10.1146/annurev-micro-102215-095605 · Cited by 449
Brinkmann, M. M., Spooner, E., Hoebe, K., Beutler, B., Ploegh, H. L., & Kim, Y.-M. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200612056 · Cited by 411
Toll-like receptors and innate immunity
Uematsu, S., & Akira, S. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0084-y · Cited by 445
Toll-Like Receptor Signaling Inhibits Hepatitis B Virus Replication In Vivo
Isogawa, M., Robek, M. D., Furuichi, Y., & Chisari, F. V. (2005) · Journal of Virology · doi:10.1128/jvi.79.11.7269-7272.2005 · Cited by 443
Hochrein, H., Schlatter, B., O’Keeffe, M. A., Wagner, C., Schmitz, F., Schiemann, M., Bauer, S., Suter, M., & Wagner, H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403555101 · Cited by 439
RIG-I and Other RNA Sensors in Antiviral Immunity
Chow, K. T., Gale, M., & Loo, Y. (2018) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053309 · Cited by 432
Devaraj, S. G., Wang, N., Chen, Z., Chen, Z., Tseng, M., Barretto, N., Lin, R., Peters, C. J., Tseng, C.-T. K., Baker, S. C., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704870200 · Cited by 411
Therapeutic Targeting of Toll-Like Receptors for Infectious and Inflammatory Diseases and Cancer
O'Neill, L. A. J., Bryant, C. E., & Doyle, S. (2009) · Pharmacological Reviews · doi:10.1124/pr.109.001073 · Cited by 429
Takeda, K., & Akira, S. (2015) · Current Protocols in Immunology · doi:10.1002/0471142735.im1412s109 · Cited by 422
Sioud, M. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.03.013 · Cited by 422
Negash, A. A., Ramos, H. J., Crochet, N., Lau, D., Doehle, B., Papić, N., Delker, D. A., Jo, J., Bertoletti, A., Hagedorn, C. H., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003330 · Cited by 424
The challenge and prospect of mRNA therapeutics landscape
Weng, Y., Li, C., Yang, T., Hu, B., Zhang, M., Guo, S., Xiao, H., Liang, X.-J., & Huang, Y. (2020) · Biotechnology Advances · doi:10.1016/j.biotechadv.2020.107534 · Cited by 417
Caron, G., Duluc, D., Frémaux, I., Jeannin, P., David, C., Gascan, H., & Delneste, Y. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.3.1551 · Cited by 417
The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling
Schoenemeyer, A., Barnes, B. J., Mancl, M. E., Latz, E., Goutagny, N., Pitha, P. M., Fitzgerald, K. A., & Golenbock, D. T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412584200 · Cited by 411
Gilliet, M. F., Conrad, C., Geiges, M. L., Cozzio, A., Thürlimann, W., Burg, G., Nestle, F. O., & Dummer, R. (2004) · Archives of Dermatology · doi:10.1001/archderm.140.12.1490 · Cited by 421
Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract
Flerlage, T., Boyd, D. F., Meliopoulos, V., Thomas, P. G., & Schultz‐Cherry, S. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00542-7 · Cited by 419
X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19
Asano, T., Boisson, B., Onodi, F., Matuozzo, D., Moncada‐Vélez, M., Renkilaraj, M. R. L. M., Zhang, P., Meertens, L., Bolze, A., Materna, M., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abl4348 · Cited by 407
Type III interferons disrupt the lung epithelial barrier upon viral recognition
Broggi, A., Ghosh, S., Sposito, B., Spreafico, R., Balzarini, F., Cascio, A. L., Clementi, N., Santis, M. D., Mancini, N., Granucci, F., et al. (2020) · Science · doi:10.1126/science.abc3545 · Cited by 403
5′-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I
Schmidt, A., Schwerd, T., Hamm, W., Hellmuth, J. C., Cui, S., Wenzel, M., Hoffmann, F. S., Michallet, M.-C., Besch, R., Hopfner, K.-P., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900971106 · Cited by 398
Loss of DExD/H Box RNA Helicase LGP2 Manifests Disparate Antiviral Responses
Venkataraman, T., Valdes, M., Elsby, R., Kakuta, S., Cáceres, G., Saijo, S., Iwakura, Y., & Barber, G. N. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.10.6444 · Cited by 400
Perry, A. K., Chow, E. K., Goodnough, J. B., Yeh, W., & Cheng, G. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040528 · Cited by 396
Toll-like receptor 8 senses degradation products of single-stranded RNA
Tanji, H., Ohto, U., Shibata, T., Taoka, M., Yamauchi, Y., Isobe, T., Miyake, K., & Shimizu, T. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2943 · Cited by 404
Control of coronavirus infection through plasmacytoid dendritic-cell–derived type I interferon
Cervantes‐Barragán, L., Züst, R., Weber, F., Spiegel, M., Lang, K. S., Akira, S., Thiel, V., & Ludewig, B. (2006) · Blood · doi:10.1182/blood-2006-05-023770 · Cited by 402
Plasmacytoid Dendritic Cells: Linking Innate and Adaptive Immunity
McKenna, K., Beignon, A., & Bhardwaj, N. (2004) · Journal of Virology · doi:10.1128/jvi.79.1.17-27.2005 · Cited by 396
Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination
Desmet, C. J., & Ishii, K. J. (2012) · Nature reviews. Immunology · doi:10.1038/nri3247 · Cited by 404
Gerosa, F., Gobbi, A., Zorzi, P., Burg, S., Brière, F., Carra, G., & Trinchieri, G. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.727 · Cited by 392
Metadata
- Authors
- Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S., & Reis e Sousa, C.
- Affiliations
- Cancer Research UK (GB)
- Immunobiology Laboratory, Cancer Research UK, London Research Institute, London WC2A 3PX, UK.
- Venue
- Science
- Published
- 2004-03-05
- Volume
- 303
- Issue
- 5663
- Pages
- 1529-1531
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1994391392
- Cited by
- 3,444
- References
- 24
- Citations by year
- 2026: 72 · 2025: 84 · 2024: 93 · 2023: 101 · 2022: 117 · 2021: 136 · 2020: 133 · 2019: 113 · 2018: 115 · 2017: 117 · 2016: 127 · 2015: 135 · 2014: 161 · 2013: 166 · 2012: 169
- FWCI
- 93.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- TLR7, single-stranded RNA, antiviral innate immunity, interferon-alpha, plasmacytoid dendritic cells, influenza virus, MyD88 signaling, RNA virus detection, inflammatory cytokines
- MeSH terms
- Animals, Antigens, Differentiation, Cells, Cultured, Dendritic Cells, Endocytosis, Immunity, Innate, Ligands, Membrane Glycoproteins, Mice, Inbred BALB C, Mice, Inbred C57BL, Influenza A virus, Poly U, Polyribonucleotides, Receptors, Cell Surface, Receptors, Immunologic, Endosomes, RNA, RNA, Viral, Signal Transduction, Cytokines, Genome, Viral, Interferon-alpha, Adaptor Proteins, Signal Transducing, Toll-Like Receptor 7, Mice, Myeloid Differentiation Factor 88
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review